Literature DB >> 17491061

Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.

J Herrstedt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17491061     DOI： 10.1093/annonc/mdm050

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.

Authors:  Paul J Hesketh; Jerry Younger; Pedro Sanz-Altamira; Melissa Hayden; Julie Bushey; Brian Trainor; Michael Krentzin; Peter Nowd; Konstantinos Arnaoutakis; Ann M Hesketh
Journal:  Support Care Cancer       Date:  2008-12-06       Impact factor: 3.603

2.  Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.

Authors:  Albert Tuca
Journal:  Cancer Manag Res       Date:  2009-12-16       Impact factor: 3.989

Review 3.  Moxibustion for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis.

Authors:  Ziling Huang; Zongshi Qin; Qin Yao; Yuanxuan Wang; Zhishun Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-12       Impact factor: 2.629

Review 4.  Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients.

Authors:  Farha Sherani; Catherine Boston; Nkechi Mba
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.